Kinfo
ICON plc logo

ICON plc

ICLRNASDAQHealthcare·US · USD
$164.40
+0.23 (+0.14%)
Prices as of October 12, 2026 · market closed

Price

Key statistics

Valuation
Market cap12.67B USD
Enterprise value15.26B USD
Trailing P/E172.81
Forward P/E13.92
PEG ratio-2.91
Price / sales1.53
Price / book1.35
Profitability
Gross margin23.23%
Operating margin9.41%
Profit margin0.33%
Return on assets0.97%
Return on equity0.29%
Income (TTM)
Revenue8.29B USD
Gross profit1.98B USD
EBITDA1.23B USD
Net income27.04M USD
Diluted EPS$0.95
Rev. growth (YoY)1.20%
Balance sheet
Total cash928.39M USD
Total debt3.53B USD
Debt / equity37.60
Current ratio0.95
Book value / share$121.55
Cash flow (TTM)
Operating cash flow1.11B USD
Levered free cash flow622.65M USD
Shares & price
Shares outstanding77.15M
Float77.10M
Held by institutions108.17%
Beta1.24
50-day MA$166.60
200-day MA$146.09
52-week high$203.91
52-week low$66.57
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-07-292.522.56+1.59%2026-06-232.432.50+2.88%2026-05-273.112.52−18.97%2026-03-130.050.07+40.00%2026-03-040.060.15+150.00%
About ICON plc

ICON plc is a clinical research organisation that provides outsourced drug and device development services to pharmaceutical, biotechnology, medical device, and public health customers. The company supports clinical development across the full product lifecycle, including study design, trial management, data solutions, site and patient access, laboratory services, and commercialization support. ICON plc also offers consulting and advisory capabilities, decentralized and hybrid trial services, real-world intelligence, and therapeutic expertise across areas such as oncology, cardiology, infectious disease, immunology, and central nervous system disorders. Its work is used to help clients run clinical programs more efficiently and bring medical treatments through development and approval pathways. Headquartered in Dublin, Ireland, ICON plc operates through a broad international network and serves organizations in multiple global markets.

Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Barry Balfe
Employees
40,200
Headquarters
Dublin, Ireland

Frequently asked questions about ICON plc